CoChat

Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective

Nauck, M. A. · 1998 · Acta Diabetologica

The DOI matches its Crossref record; 145 of the 146 references it cites were found in a registry or an index.

Abstract

Glucagon-like peptide 1 (GLP-1) is a physiological incretin hormone from the lower gastrointestinal tract, partially explaining the augmented insulin response after oral compared to intravenous glucose administration in normal humans. In addition, GLP-1 also lowers glucagon concentrations, slows gastric emptying, stimulates (pro)insulin biosynthesis, and reduces food intake upon intracerebroventricular administration in animals. Therefore, GLP-1 offers some interesting perspective for the treatment of type 2, and perhaps also for type 1 diabetic patients. The other incretin hormone, gastric inhibitory polypeptide (GIP), has lost almost all its activity in type-2 diabetic patients. In contrast, GLP-1 glucose-dependently stimulates insulin secretion in type-2 diabetic patients and exogenous administration of GLP-1 ([7-37] or [7-36 amide]) in doses elevating plasma concentrations to approximately three to four times physiological postprandial levels fully normalizes fasting hyperglycaemia and reduces postprandial glycaemic increments. Due to rapid proteolytic cleavage, which results in an inactive or even antagonistic fragment. GLP-1 [9-36 amide], and to rapid elimination, the half-life of GLP-1 is too short to maintain therapeutic plasma levels for sufficient periods by subcutaneous injections of the natural peptide hormone. Current research aims to characterize GLP-1 analogues with more suitable pharmacokinetic properties than the original peptide. Given the large amount of GLP-1 present in L cells, it also appears worthwhile to search for more agents that could 'mobilize' this endogenous pool of GLP-1.

Overview

Integrity signals

Registry

Crossref · 10.1007/s005920050116

Cites

145 of 145 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 145 references

Cited by

See all 96

Metadata

Authors
Nauck, M. A.
Affiliations
Universitätsklinikum Knappschaftskrankenhaus Bochum (DE)
Corresponding author
Nauck, M. A.
Venue
Acta Diabetologica
Published
1998-10-23
Volume
35
Issue
3
Pages
117-129
ISSN
  • 0940-5429 (ISSN-L)
  • 1432-5233
OpenAlex
W2079136334
Cited by
94
References
146
Citations by year
2026: 4 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 2 · 2021: 5 · 2020: 1 · 2019: 1 · 2017: 2 · 2015: 4 · 2014: 2 · 2013: 7 · 2012: 3
FWCI
3.14
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Acta Diabetologica (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
glucagon-like peptide-1, incretins, type 2 diabetes, type 1 diabetes, insulin secretion, glucose-dependent insulinotropic polypeptide, GLP-1 analogues, pharmacokinetics, gastric emptying, dietary intake, gastrointestinal hormones, L cells, fasting hyperglycemia, postprandial blood glucose
MeSH terms
Animals, Cerebral Ventricles, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Feeding Behavior, Gastric Emptying, Glucagon, Glucose, Humans, Insulin, Models, Biological, Peptide Fragments, Proinsulin, Protein Precursors, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.